Inspire Medical Systems (NYSE:INSP) Shares Gap Down After Analyst Downgrade
Inspire Medical Systems, Inc. (NYSE:INSP – Get Free Report) gapped down before the market opened on Tuesday after Truist Financial lowered their price target on the stock from $250.00 to $235.00. The stock had previously closed at $180.
Inspire Medical shares dipped — but have since mostly recovered — following news of a government investigation following Q4 ...
Inspire Medical Systems said it is cooperating with U.S. Justice Department probe of allegations into allegations of false claims related to its Inspire system apnea implant. Shares fall 5.5% to $171 ...
Medical technology company Inspire Medical Systems (NYSE:INSP) will be reporting results tomorrow after market close. Here’s what you need to know. Inspire Medical Systems beat analysts ...
Inspire Medical Systems, Inc. announced preliminary fourth quarter and full year 2024 financial results, revealing anticipated revenues of approximately $239.5 million to $239.7 million for Q4 ...
Inspire Medical (INSP) disclosed that on January 17, it received a civil investigative demand from the Department of Justice U.S. Attorney’s ...
The promotion and reimbursement practices for the medtech company’s implantable CPAP alternative are under scrutiny.
Chairman and Chief Executive Officer of Inspire Medical Systems. “We are also excited to announce the first implants of the new Inspire V neurostimulation system, and a new organizational ...
Inspire Medical's both geographic segments witness strong revenue growth on the back of solid product demand in the fourth ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback